THROMBOLYSIS IN VENOUS THROMBOEMBOLISM - AN INTERNATIONAL PERSPECTIVE

被引：5

作者：

GOLDHABER, SZ ^{[1
]}

机构：

[1] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA

来源：

CHEST | 1990年 / 97卷 / 04期

关键词：

D O I：

10.1378/chest.97.4_Supplement.176S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：S176 / S181

页数：6

共 27 条

[1] THE THROMBOLYTIC AND HEMORRHAGIC EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR - INFLUENCE OF DOSAGE REGIMENS IN RABBITS [J].

AGNELLI, G ;

BUCHANAN, MR ;

FERNANDEZ, F ;

HIRSH, J .

THROMBOSIS RESEARCH, 1985, 40 (06) :769-777

[2]

AGNELLI G, 1985, BLOOD, V66, P399

[3]

[Anonymous], 1988, LANCET, V2, P349

[4]

[Anonymous], 1986, LANCET, V1, P397

[5]

[Anonymous], 1973, CIRCULATION S2, V47 and 48, P1

[6]

BROWN W D, 1989, Chest, V95, p276S, DOI 10.1378/chest.95.5.276S

[7]

CHARBONNIER B, 1989, SEP INT SAT S EUR C

[8] EARLY REVERSAL OF RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY-EMBOLISM AFTER TREATMENT WITH INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR [J].

COME, PC ;

KIM, D ;

PARKER, JA ;

GOLDHABER, SZ ;

BRAUNWALD, E ;

MARKIS, JE .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (05) :971-978

[9]

GOLDHABER S Z, 1989, Chest, V95, p282S, DOI 10.1378/chest.95.5_Supplement.282S

[10]

GOLDHABER SZ, 1986, LANCET, V2, P886

← 1 2 3 →